650 results on '"Bouma, Gerd"'
Search Results
2. Feces: samenstelling en diagnostiek
3. Diagnostic criteria and long-term outcomes in AIH-PBC variant syndrome under combination therapy
4. Cerebellar presence of immune cells in patients with neuro-coeliac disease
5. Activated CD27+PD-1+ CD8 T Cells and CD4 T Regulatories Dominate the Tumor Microenvironment in Refractory Celiac Disease Type II
6. Enduring Clinical Remission in Refractory Celiac Disease Type II with Tofacitinib: An Open-Label Clinical Study
7. Standardizing Randomized Controlled Trials in Celiac Disease: An International Multidisciplinary Appropriateness Study
8. Potential of Mesalazine Therapeutic Drug Monitoring by Measuring Fecal Excretion in Patients With Ulcerative Colitis
9. Superior Effectiveness of Tofacitinib Compared to Vedolizumab in Anti-TNF-experienced Ulcerative Colitis Patients: A Nationwide Dutch Registry Study
10. OS-015 Time to complete biochemical response and disease progression in autoimmune hepatitis
11. Enduring clinical remission in refractory celiac disease type II with tofacitinib: an open-label clinical study
12. Celiac disease: New therapies on the horizon
13. Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial
14. Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study
15. Methotrexate accumulation in target intestinal mucosa and white blood cells differs from non‐target red blood cells of patients with Crohn's disease.
16. Single-Cell Analysis of Refractory Celiac Disease Demonstrates Inter- and Intra-Patient Aberrant Cell Heterogeneity
17. IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes.
18. Drug withdrawal in patients with autoimmune hepatitis in long-term histological remission: A prospective observational study
19. INSPECT: A Retrospective Study to Evaluate Long-term Effectiveness and Safety of Darvadstrocel in Patients With Perianal Fistulizing Crohn’s Disease Treated in the ADMIRE-CD Trial
20. Rapid Response to Treatment of Autoimmune Hepatitis Associated With Remission at 6 and 12 Months
21. Editorial: Monitoring methotrexate polyglutamates in Crohn's disease—Authors' reply
22. Safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group study
23. Vitamin A metabolism and mucosal immune function are distinct between BALB/c and C57BL/6 mice
24. Predniso(lo)ne Dosage and Chance of Remission in Patients With Autoimmune Hepatitis
25. Association Between Black Race and Presentation and Liver-Related Outcomes of Patients With Autoimmune Hepatitis
26. Increased Mortality Among Patients With vs Without Cirrhosis and Autoimmune Hepatitis
27. Clinical Course of Nodular Regenerative Hyperplasia in Thiopurine Treated Inflammatory Bowel Disease Patients
28. Efficacy and Safety of Budesonide, vs Mesalazine or Placebo, as Induction Therapy for Lymphocytic Colitis
29. Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome: First report of the IAIHG retrospective registry.
30. Transient elastography to assess liver stiffness in patients with inflammatory bowel disease
31. CD4 T-cell cytokines synergize to induce proliferation of malignant and nonmalignant innate intraepithelial lymphocytes
32. Lack of biochemical response after diagnosis is associated with cirrhosis development during follow-up in autoimmune hepatitis
33. Interleukin 12
34. Therapeutic drug monitoring of methotrexate in patients with Crohn's disease.
35. Voedselovergevoeligheid
36. A meta-analysis of methotrexate polyglutamates in relation to efficacy and toxicity of methotrexate in inflammatory arthritis, colitis and dermatitis
37. Intestinal epithelial cell transported TLR2 ligand stimulates Ly6C+ monocyte differentiation in a G-CSF dependent manner
38. Gamma-Delta T Lymphocytes in the Diagnostic Approach of Coeliac Disease
39. Superior Effectiveness of Tofacitinib Compared to Vedolizumab in Anti-TNF-experienced Ulcerative Colitis Patients: A Nationwide Dutch Registry Study
40. Electronic Nose Sensor Drift Affects Diagnostic Reliability and Accuracy of Disease-Specific Algorithms
41. A meta‐analysis of methotrexate polyglutamates in relation to efficacy and toxicity of methotrexate in inflammatory arthritis, colitis and dermatitis
42. Fcα Receptor-1-Activated Monocytes Promote B Lymphocyte Migration and IgA Isotype Switching
43. Salivary Calprotectin Is not a Useful Biomarker to Monitor Disease Activity in Patients with Inflammatory Bowel Disease
44. A locus at 7p14.3 predisposes to refractory celiac disease progression from celiac disease
45. Methotrexate and Thioguanine Rescue Therapy for Conventional Thiopurine Failing Ulcerative Colitis Patients: A Multi-center Database Study on Tolerability and Effectiveness
46. Role of age in presentation, response to therapy and outcome of autoimmune hepatitis
47. Salivary Function and Oral Health Problems in Crohn’s Disease Patients
48. Sex-Related Differences in Patients With Inflammatory Bowel Disease: Results of 2 Prospective Cohort Studies
49. Optimizing Thiopurine Therapy in Inflammatory Bowel Disease Among 2 Real-life Intercept Cohorts: Effect of Allopurinol Comedication?
50. Non-Responsive and Refractory Coeliac Disease: Experience from the NHS England National Centre
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.